Zeitschrift
American Journal of Clinical Dermatology
-
Adis Drug EvaluationRuxolitinib Cream 1.5%: A Review in Mild to Moderate Atopic Dermatitis
-
Review ArticleThe Current Treatment Landscape of Cutaneous Squamous Cell Carcinoma
-
Original Research ArticleEarly Itch Response with Abrocitinib Is Associated with Later Efficacy Outcomes in Patients with Moderate-to-Severe Atopic Dermatitis: Subgroup Analysis of the Randomized Phase III JADE COMPARE Trial
-
Current OpinionReal-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion